This activity is expired and is no longer available for CME credit.


Treatment Protocols in Age-related Macular Degeneration and Diabetic Retinopathy: An Age of Discovery

Author(s)/Faculty: Andrew A. Moshfeghi, MD, MBA; Darius M. Moshfeghi, MD
Release Date: 1/30/2020Expiration Date: 1/29/2021
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
The integration of intravitreal anti-vascular endothelial growth factor (VEGF) therapies into treatment protocols for patients with retinal disease provides for enhanced visual acuity outcomes and the potential to delay disease progression. As treatment protocols for diabetic retinopathy (DR) and neovascular age-related macular degeneration (nAMD) continue to be evaluated and refined, questions remain pertaining to optimizing treatment dosing for the long-term benefit and management of patients with DR and nAMD. In this educational activity, experts in the field evaluate the latest evidence for the optimization of treatment dosing and management of patients with DR as well as differentiate injection protocols that have the potential to enhance long-term benefits in the treatment of nAMD.